Health
Study identifies therapeutic targets for most lethal pancreatic cancer – Drug Target Review
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Posted: 15 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Using preclinical models, researchers have identified two promising therapeutic targets for the most aggressive and lethal form of pancreatic cancer, adenosquamous cancer of the pancreas (ASCP).
The team of researchers led by Mayo Clinic and the Translational Genomics Research Inst…
-
Noosa News16 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General14 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News15 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Business17 hours agoSolid superannuation gains continue to roll in